Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

646 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma

NCT00656812

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Universitätsklinikum Graz Graz, Austria
  • Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
  • Krankenhaus der Stadt Linz Linz, Austria
  • Universitaetsklinik f. Innere Medizin III Salzburg, Austria
View Trial Details
Completed

Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)

NCT01164267

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • General Hospital AKH Vienna, Austria
  • Policlinico S. Orsola Malpighi Bologna, Italy
  • Humanitas Milan, Italy
  • San Raffaele Hospital Milan, Italy
View Trial Details
Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mercy Medical Center Canton, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States
View Trial Details
Completed

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

NCT00608374

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Newcastle Mater Misericordiae Hospital Waratah, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Queen Elizabeth Hospital Woodville, South Australia, Australia
View all 49 locations
View Trial Details

Related conditions